Related Articles
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model
Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL
Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment
Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer
Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy